Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Factor VII anticorps (C-Term)

Cet anticorps Lapin Polyclonal détecte spécifiquement Factor VII dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN3042925

Aperçu rapide pour Factor VII anticorps (C-Term) (ABIN3042925)

Antigène

Voir toutes Factor VII (F7) Anticorps
Factor VII (F7) (Coagulation Factor VII (F7))

Reactivité

  • 55
  • 11
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 51
  • 12
  • 8
  • 2
  • 1
Lapin

Clonalité

  • 63
  • 11
Polyclonal

Conjugué

  • 48
  • 15
  • 4
  • 3
  • 2
  • 1
  • 1
Cet anticorp Factor VII est non-conjugé

Application

  • 57
  • 27
  • 23
  • 18
  • 17
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 441-453, C-Term

    Fonction

    Anti-Factor VII/F7 Antibody Picoband®

    Séquence

    SQYIEWLQKL MRS

    Réactivité croisée (Details)

    No cross-reactivity with other proteins

    Attributs du produit

    Rabbit IgG polyclonal antibody for Coagulation factor VII(F7) detection. Tested with WB in Human.
    Gene Name: coagulation factor VII(serum prothrombin conversion accelerator)
    Protein Name: Coagulation factor VII

    Purification

    Immunogen affinity purified.

    Immunogène

    A synthetic peptide corresponding to a sequence at the C-terminus of human Factor VII.

    Isotype

    IgG
  • Indications d'application

    Western blot, 0.1-0.5 μg/mL, Human
    1. Di Bitondo, R., Hall, A. J., Peake, I. R., Iacoviello, L., Winship, P. R. Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region. Hum. Molec. Genet. 11: 723-731, 2002. 2. Millar, D. S., Kemball-Cook, G., McVey, J. H., Tuddenham, E. G. D., Mumford, A. D., Attock, G. B., Reverter, J. C., Lanir, N., Parapia, L. A., Reynaud, J., Meili, E., von Felton, A., Martinowitz, U., Prangnell, D. R., Krawczak, M., Cooper, D. N. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum. Genet. 107: 327-342, 2000. 3. Zur, M., Nemerson, Y. Tissue factor pathways of blood coagulation.In: Bloom, A. L., Thomas, D. P. : Haemostasis and thrombosis. Edinburgh: Churchill Livingstone (pub.) 1981.

    Commentaires

    Antibody can be supported by chemiluminescence kit ABIN921124 in WB.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Concentration

    500 μg/mL

    Buffer

    Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.

    Agent conservateur

    Thimerosal (Merthiolate), Sodium azide

    Précaution d'utilisation

    This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.

    Date de péremption

    12 months
  • Antigène

    Factor VII (F7) (Coagulation Factor VII (F7))

    Autre désignation

    F7

    Sujet

    Synonyms: Coagulation factor VII,3.4.21.21,Proconvertin,Serum prothrombin conversion accelerator,SPCA,Eptacog alfa,Factor VII light chain,Factor VII heavy chain,F7,

    Tissue Specificity: Plasma.

    Background: F7 (Coagulation Factor VII), also known as proconvertin, is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. The F7 gene maps to chromosome 13q34 (Millar et al., 2000). Synthesis of factors VII and X, as well as factors II and IX, takes place in the liver and requires vitamin K. Structural homologies of these factors, which are precursors of serine proteases, have been shown (Zur and Nemerson, 1981). Di Bitondo et al. (2002) used reporter gene analysis to show that inclusion of promoter regions of F7 reduced transcription activity in the presence of estrogenic factors. The effect was independent of promoter polymorphic haplotype.

    Sequence Similarities: Belongs to the peptidase S1 family.

    Poids moléculaire

    52 kDa

    UniProt

    P08709

    Pathways

    Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Vous êtes ici:
Chat with us!